^
    Apply
    Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression (NCT05472857)
    Phase 1
    Suzhou Immunofoco Biotechnology Co., Ltd
    Recruiting
    Last update posted :
    03/06/2024
    Initiation :
    08/08/2022
    Primary completion :
    12/01/2024
    Completion :
    12/01/2024
    CLDN18
    |
    IMC002
    A Phase I Trial to Evaluate the Safety of IMC002 in Advanced Digestive System Tumors (NCT05946226)
    Phase 1
    Suzhou Immunofoco Biotechnology Co., Ltd
    Recruiting
    Last update posted :
    09/28/2023
    Initiation :
    09/07/2023
    Primary completion :
    12/01/2025
    Completion :
    12/31/2025
    CLDN18 • IL6 • IL2 • IL10
    |
    CLDN18.2 positive
    |
    IMC-001 • IMC001 • IMC002